Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life

Annalisa Panico; Gelsy Arianna Lupoli; Francesca Marciello; Roberta Lupoli; Marianna Cacciapuoti; Addolorata Martinelli; Luciana Granieri; Daniela Iacono; Giovanni Lupoli

doi:10.12659/MSM.881905

01 August 2011

Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life

Annalisa Panico^ABDE, Gelsy Arianna Lupoli^DE, Francesca Marciello^C, Roberta Lupoli^B, Marianna Cacciapuoti^E, Addolorata Martinelli^F, Luciana Granieri^F, Daniela Iacono^B, Giovanni Lupoli^ADE

DOI: 10.12659/MSM.881905

Med Sci Monit 2011; 17(8): CR442-448

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life

Your Privacy